$ISCO News
Last published 4y ago
- 4y agoISCOInternational Stem Cell Corporation Announces 2021 Fourth Quarter and Year-End ResultsACCESS NewswireSAN DIEGO, CA / ACCESSWIRE / March 30, 2022 / International Stem Cell Corporation (OTCQX:ISCO) (www.internationalstemcell.com) ("ISCO" or "the Company"), a California-based clinical stage biotechnology company developing novel stem cell-based therapies a
- 4y agoDMTTFETONISCOLBPSSmall Pharma Strengthens Board With Appointment of Paul Maier as Independent DirectorGlobeNewswireLONDON, Nov. 18, 2021 (GLOBE NEWSWIRE) -- Small Pharma Inc. (TSXV:DMT) (OTCQB:DMTTF) (the "Company" or "Small Pharma"), a neuropharmaceutical company focused on psychedelic-assisted therapies, announces that Mr. Paul Maier has been appointed as a non-e
- 5y agoISCOInternational Stem Cell Corporation Announces Successful Completion of Its Phase 1 Clinical Trial in Parkinson's DiseaseACCESS NewswireCARLSBAD, CA / ACCESSWIRE / June 30, 2021 / International Stem Cell Corporation (OTCQB:ISCO) (www.internationalstemcell.com) ("ISCO" or "the Company"), a California-based clinical stage biotechnology company developing stem cell-based therapies and biome